This list is an analysis based on recent market events. It's not an investment recommendation.
About
CF PharmTech, Inc. engages in research and development, production, and sale of respiratory drugs and other related medical products in China. It offers Shufeimin, an azelastine hydrochloride and fluticasone propionate nasal spray; ChangQi, a budesonide inhalation suspension solution; ChangShu, a salbutamol sulfate inhalation solution; and piezoelectric mesh nebulizer, electric nasal cleaner, BFS hypertonic and physiological seawater nasal cleansing fluid products under the ChangShu name. The company also develops products for the treatment of respiratory diseases, including allergic rhinitis, asthma, chronic obstructive pulmonary, respiratory infection, pulmonary fibrosis, pulmonary hypertension, and other respiratory diseases. In addition, it develops therapeutic products for respiratory and other diseases, such as inhalation spray and aerosol, dry powder inhaler, nebulization, nasal spray products, as well as liposomes. Further, the company provides CDMO/CMO technical services. CF PharmTech, Inc. was formerly known as Suzhou CF PharmTech Co., Ltd. CF PharmTech, Inc. was founded in 2007 and is based in Suzhou, China.
The current price of 2652.HK is HK$5.07 HKD — it has decreased by -4.07% in the past 24 hours. Watch CF PharmTech stock price performance more closely on the chart.
What is CF PharmTech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Hong Kong Exchange exchange CF PharmTech stocks are traded under the ticker 2652.HK.
Is CF PharmTech stock price growing?▼
2652.HK stock has fallen by -9.95% compared to the previous week, the month change is a -25.99% fall, over the last year CF PharmTech has showed a -83.32% decrease.
What is CF PharmTech market cap?▼
Today CF PharmTech has the market capitalization of 2.06B
When is the next CF PharmTech earnings date?▼
CF PharmTech is going to release the next earnings report on March 3, 2027.
What were CF PharmTech earnings last quarter?▼
2652.HK earnings for the last quarter are -0.03 HKD per share, whereas the estimation was N/A HKD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A HKD per share.
What is CF PharmTech revenue for the last year?▼
CF PharmTech revenue for the last year amounts to 475.71M HKD.
What is CF PharmTech net income for the last year?▼
2652.HK net income for the last year is 2.25M HKD.
How many employees does CF PharmTech have?▼
As of November 3, 2026, the company has 540 employees.
In which sector is CF PharmTech located?▼
CF PharmTech operates in the Health & Wellness sector.